Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
作者信息
Cornaby A J, Simpson M A, Madras P N, Dempsey R A, Clowes G H, Monaco A P
机构信息
Department of Surgery, New England Deaconess Hospital, Boston, MA 02151.
出版信息
Transplant Proc. 1989 Feb;21(1 Pt 2):1861-2.
PMID:2652604
Abstract
摘要
相似文献
1
Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
Transplant Proc. 1989 Feb;21(1 Pt 2):1861-2.
2
A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients.
Transplant Proc. 1989 Feb;21(1 Pt 2):1863.
3
Evaluation of serum immunological parameters in acute renal allograft rejection.急性肾移植排斥反应中血清免疫学参数的评估。
Transplant Proc. 1996 Jun;28(3):1443-4.
4
Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients.环孢素与硫唑嘌呤治疗的肾移植患者中白细胞介素-2受体阳性细胞水平
Transplant Proc. 1989 Feb;21(1 Pt 2):1469.
5
Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology.
Transplant Proc. 1990 Oct;22(5):2284-5.
6
Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.
Transplant Proc. 1989 Feb;21(1 Pt 2):2275-6.
7
Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients.
Transplant Proc. 1989 Feb;21(1 Pt 1):299-300.
8
Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection.人类肾移植排斥反应中炎症的细胞和分子标志物之间的关系。
Transplant Proc. 1987 Feb;19(1 Pt 2):1644-5.
9
BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.尽管发生急性移植排斥反应，BT563仍能显著降低血浆可溶性白细胞介素-2受体水平。
Transplant Proc. 1996 Dec;28(6):3103-5.
10
Urine sediment cytology in the management of renal allograft recipients.
Transplant Proc. 1989 Feb;21(1 Pt 2):1842-3.
引用本文的文献
1
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.T细胞生长因子白细胞介素-2偶尔会成为自身抗体的靶点，有资格作为治疗过敏、自身免疫和癌症的药物：国际变态反应学会（CIA）2024年更新。
Int Arch Allergy Immunol. 2024;185(3):286-300. doi: 10.1159/000533677. Epub 2023 Dec 12.
2
Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients.
Doc Ophthalmol. 1993;83(1):83-9. doi: 10.1007/BF01203574.
Zotero 插件